HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 973-984 of 1,811
Behavioral study icon
CompletedNCT02917109

LearningRx Cognitive Training for ADHD

Official study title

LearningRx Cognitive Training for ADHD: A Multiple Baseline Study Across Cases

This study has finished and is no longer accepting participants.

In Colorado Springs
ADHDBehavioural studyAges 15–22
Countries
United States
Sponsor
Gibson Institute of Cognitive Research
Behavioral study icon
CompletedNCT04779333

Lifestyle Enhancement for ADHD Program 2

Official study title

Lifestyle Enhancement for ADHD Program (LEAP) Study 2

This study has finished and is no longer accepting participants.

In Seattle
ADHDBehavioural studyAges 6–10
Countries
United States
Sponsor
Seattle Children's Hospital
Drug study icon
TerminatedNCT02170298

Lisdexamfetamine's Effect In ADHD in the Brain and Cognition

Official study title

Effects of Lisdexamfetamine on Cognitive Control and Reward Response in Adolescents and Young Adults With ADHD: Neural and Clinical Outcomes

This study ended early.

In Sacramento
ADHDMedication studyAges 12–30
Countries
United States
Sponsor
University of California, Davis
Other study type icon
CompletedNCT05290311

Long-Term Effects of CBT on Quality of Life in Adults With ADHD

Official study title

What Are the Long-Term Effects of Cognitive-Behavioural Therapy on Quality of Life in Adult Patients With ADHD?

This study has finished and is no longer accepting participants.

In Amsterdam
ADHDObservational studyAges 18+
Countries
Netherlands
Sponsor
Amsterdam UMC, location VUmc
Drug study icon
CompletedNCT00190684

Long-Term, Open Label Atomoxetine Study

What is this study about?

Researchers studied atomoxetine, tracking side effects to assess long-term safety in people with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
ADHDMedication studyAges 6–18
Countries
United States, Australia, France, + 10 others
Sponsor
Eli Lilly and Company
Drug study icon
CompletedNCT01533493

Memantine for Executive Dysfunction in Adults With ADHD: A Study

Official study title

Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study

This study has finished and is no longer accepting participants.

In Boston
ADHDMedication studyAges 18–50
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.